CellaVision ABCVLLY +12.06%69 Operating Margin % is 17.13% as of Mar. 2026, which is 37% below its 10-year median of 27.02. GuruFocus rates CVLLY with a GF Score™ of 69/100 and a GF Value™ of $12.48 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 816 Medical Devices & Instruments companies, CellaVision AB ranks better than 90.81% on this metric.
CellaVision AB operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for CellaVision AB's Operating Margin % or its related term are showing as below:
CVLLY'
s Operating Margin % Range Over the Past 10 Years
Min: 23.39 Med: 27.02 Max: 30.59
Current: 23.74
CVLLY's Operating Margin % is ranked better than 90.81% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs CVLLY: 23.74
CellaVision AB's 5-Year Average Operating Margin % Growth Rate was 0.50% per year.
CellaVision AB (OTCPK:CVLLY) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
CellaVision AB Operating Margin % Related Terms
CellaVision AB Operating Margin % Historical Data
* Premium members only.
The historical data trend for CellaVision AB's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVLLY vs ABT, SYK, MDT: Operating Margin % Comparison
For the Medical Devices subindustry, CellaVision AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellaVision AB Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where CellaVision AB's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
CellaVision AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellaVision AB (CVLLY) has a Operating Margin % of 17.13% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on CellaVision AB and its competitors. This is 37% below median its historical median of 27.02. Over the past decade, CellaVision AB's Operating Margin % has ranged from 23.39 to 30.59. According to the industry distribution chart, CellaVision AB ranks #75 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 9.2%.
Is CellaVision AB's Operating Margin % too high?
CellaVision AB's current Operating Margin % of 17.13% is 37% below median its 10-year median of 27.02. Over the past 10 years, this metric has ranged from a low of 23.39 to a high of 30.59. The Medical Devices & Instruments industry median Operating Margin % is 3.47. CellaVision AB's value of 17.13% is 394.4% above this industry median. Based on the distribution chart, CellaVision AB ranks #75 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, CellaVision AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CellaVision AB ranks #75 out of 816 companies for Operating Margin %. This places CellaVision AB in the top 9% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. CellaVision AB's value of 17.13% is 394.4% above this benchmark. Historically, CellaVision AB's own Operating Margin % has ranged from 23.39 to 30.59 over the past decade. While the company's 10-year median is 27.02 vs. the industry median of 3.47, CellaVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CellaVision AB's current Operating Margin % of 17.13% is 394.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on CellaVision AB and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CellaVision AB's current Operating Margin % is 17.13%, which is 37% below median its own 10-year median of 27.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
Based on GuruFocus' analysis, CellaVision AB (CVLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.48, compared to a current price of $7.06 — trading 43.4% below its estimated fair value. The current Operating Margin % is 17.13%, which is 37% below median its 10-year median of 27.02 and 394.4% above the Medical Devices & Instruments industry median of 3.47. CellaVision AB's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For CellaVision AB (CVLLY), the current Operating Margin % is 17.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellaVision AB (CVLLY) Overvalued in 2026?
Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued.
The current stock price of $7.06 is trading 43.4% below its estimated GF Value™ of $12.48.
GuruFocus considers CellaVision AB to be Significantly Undervalued.
Key valuation signals for CVLLY:
Operating Margin %: 17.13% (37% below median its 10-year median of 27.02)
GF Value™: $12.48 vs. price of $7.06 (43.4% below fair value)
Industry Position: 394.4% above the Medical Devices & Instruments median (#75 of 816)
No single metric tells the full story. See the CVLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
69GF Score
Get the complete analysis for CVLLY
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVLLY has been successfully added to your 
